Hims & Hers said Wednesday that it will begin offering GLP-1 microdosing treatments, doubling down on selling copycat versions of the blockbuster weight-loss drugs made by Novo Nordisk
[2] Studies show that more than half of people feel it at some point, usually when first starting the medication or after a dose increase
Rate of loss : Weight loss tends to begin within the first 4 to 8 weeks, often at a slower pace
I was 41 at the time, sitting at about 182 lbs at 55
The FDA is in a public comment period - closing June 29, 2026 - on a proposal to formally exclude semaglutide and tirzepatide from the 503B Bulk Drug Substances List, a move that would permanently close large-scale compounding pathways for these active ingredients even in a future shortage
The table below maps the standard titration ladder used across Phase 2 and the TRIUMPH Phase 3 programme [1][6]